Teens aged 12 to 15 will soon be able to receive booster jabs of the Pfizer-BioNTech COVID-19 vaccine under new guidance expected to be announced by the FDA next week.
Teens 12 to 15 will soon be able to receive booster jabs of the Pfizer-BioNTech COVID-19 vaccine under new guidance expected to be announced by the US Food and Drug Administration next week.
In addition, young children ages 5 to 11 with immune deficiencies are also expected to be authorized for the third jabs under the agency’s new guidance.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
FDA authorizes at-home rapid COVID testIt's the FDA's second approval of an at-home COVID test in less than a week as shortages continue.
続きを読む »
FDA says rapid Covid antigen tests may be less sensitive in detecting omicronCase numbers are surging across the country, prompting high demand for at-home testing kits.
続きを読む »
Experts Warn Merck's FDA-Authorized Covid Pill Could 'Create Breeding Ground for Mutant Viruses''The FDA and Merck have essentially engaged the public in a gamble without public debate,' argues Stanford University's michaelzlin.
続きを読む »
FDA says rapid Covid antigen tests may be less sensitive in detecting omicronThe Food and Drug Administration said Tuesday that preliminary research shows some rapid antigen tests may be less sensitive at detecting the highly contagious omicron variant of the coronavirus.
続きを読む »
FDA says rapid COVID-19 antigen tests may be less sensitive in detecting omicronThe Food and Drug Administration said Tuesday that preliminary research shows some rapid antigen tests may be less sensitive at detecting the highly contagious
続きを読む »
FDA authorizes Merck’s COVID-19 antiviral pillICYMI: On 12/23, the FDA authorized the emergency use of Merck’s antiviral pill for adults over the age of 18 who have tested positive for COVID-19 and are at high risk for severe disease
続きを読む »